Biosafety and biocompatibility assessment of Prussian blue nanoparticles in vitro and in vivo
Abstract
Aim: To investigate the effects of the different morphological characteristics of Prussian blue nanoparticles (PB NPs) on their biocompatibility and biosafety. Materials & methods: PB NPs with different sizes, shapes and charges were synthesized and their biosafety and biocompatibility performance were systematically compared in vitro and in vivo. Results: Increased size and positive charge of PB NPs adversely affected cell viability, while improving their peroxidase activity and photothermal conversion efficiency. In vivo analysis demonstrated good biocompatibility of PB NPs, without retention in the organs, but increased size retarded their metabolism. Meanwhile, increased size and positive charge adversely affected hepatic and renal function. Conclusion: This comprehensive exploration of biosafety and biocompatibility provides strong evidences for the use of PB NPs as nanodrug carrier and/or imaging agent.
Papers of special note have been highlighted as: • of interest; •• of considerable interest
References
- 1. . Progress in applications of Prussian blue nanoparticles in biomedicine. Adv. Healthc. Mater. 7(20), e1800347 (2018).
- 2. Perfluoropentane-encapsulated hollow mesoporous Prussian blue nanocubes for activated ultrasound imaging and photothermal therapy of cancer. ACS Appl. Mater. 7(8), 4579–4588 (2015).
- 3. . Nanochannel array device operating through Prussian blue nanoparticles for sensitive label-free immunodetection of a cancer biomarker. Biosens. Bioelectron. 67, 107–114 (2015).
- 4. Carbon dots/Prussian blue satellite/core nanocomposites for optical imaging and photothermal therapy. ACS Appl. Mater. 10(1), 1084–1092 (2018).
- 5. Mn2+-doped prussian blue nanocubes for bimodal imaging and photothermal therapy with enhanced performance. ACS Appl. Mater. 7(21), 11575–11582 (2015).
- 6. . Prussian blue nanoparticles as a versatile photothermal tool. Molecules 23(6), 1414 (2018).
- 7. Novel photo-thermally active polyvinyl alcohol-Prussian blue nanoparticles hydrogel films capable of eradicating bacteria and mitigating biofilms. Nanotechnology 30(29), 295702 (2019).
- 8. PB@PDA@Ag nanosystem for synergistically eradicating MRSA and accelerating diabetic wound healing assisted with laser irradiation. Biomaterials 243, 119936 (2020).
- 9. RBC membrane camouflaged Prussian blue nanoparticles for gamabutolin loading and combined chemo/photothermal therapy of breast cancer. Biomaterials 217, 119301 (2019).
- 10. Prussian blue nanozyme with multienzyme activity reduces colitis in mice. ACS Appl. Mater. 10(31), 26108–26117 (2018).
- 11. . Human HSP70 promoter-based Prussian blue nanotheranostics for thermo-controlled gene therapy and synergistic photothermal ablation. Adv. Funct. Mater. 28(32), 1802026 (2018).
- 12. Dual purpose Prussian blue nanoparticles for cellular imaging and drug delivery: a new generation of T1-weighted MRI contrast and small molecule delivery agents. J. Mater. Chem. 20(25), 5251–5259 (2010).
- 13. . Prussian blue nanoparticles and their analogues for application to cancer theranostics. Nanomedicine (Lond.) 11(6), 569–572 (2016).
- 14. Toxicity responses of different organs of zebrafish (Danio rerio) to silver nanoparticles with different particle sizes and surface coatings. Environ. Pollut. 246, 414–422 (2019).
- 15. . Uptake, distribution, clearance and toxicity of iron oxide nanoparticles with different sizes and coatings. Sci. Rep. 8(1), 2082 (2018).
- 16. . Particle-size-dependent toxicity and immunogenic activity of mesoporous silica-based adjuvants for tumor immunotherapy. Acta Biomater. 9(7), 7480–7489 (2013). • Some widely used nanomaterials have shown toxicity related with to size, shape and charge.
- 17. Inhibition of amyloid beta toxicity in zebrafish with a chaperone-gold nanoparticle dual strategy. Nat. Commun. 10(1), 3780 (2019).
- 18. An erythrocyte membrane coated mimetic nano-platform for chemo-phototherapy and multimodal imaging. RSC Adv. 9(48), 27911–27926 (2019).
- 19. . Preparation of Prussian blue nanoparticles with single precursor. Colloids Surf. A Physicochem. Eng. Asp. 302(1–3), 326–329 (2007).
- 20. . Spontaneous nucleation of monodisperse silver halide particles from homogeneous gelatin solution I: silver chloride. Colloids Surf. A Physicochem. Eng. Asp. 164(2–3), 183–203 (2000). •• Size control theory has been developed to offer a theoretical background for the size control of monodispersed particles in closed systems.
- 21. . Prussian blue nanoparticles operate as a new generation of photothermal ablation agents for cancer therapy. Chem. Commun. (Camb.) 48(94), 11567–11569 (2012). • Prussian blue nanoparticles have good catalase activity and this activity is determined by the structure.
- 22. . Nano-bio interaction between graphite oxide nanoparticles and human blood components. Eur. J. Inorg. Chem. 2012(32), 5343–5349 (2012).
- 23. Size, Shape and protein corona determine cellular uptake and removal mechanisms of gold nanoparticles. Small 14(42), e1801451 (2018).
- 24. Predictive value of the surface-enhanced resonance raman scattering-based MTT assay: a rapid and ultrasensitive method for cell viability in situ. Anal. Chem. 85(15), 7361–7368 (2013).
- 25. Prussian blue with intrinsic heme-like structure as peroxidase mimic. Nano Res. 11(9), 4905–4913 (2018).
- 26. Anchoring of Prussian blue nanoparticles on polydopamine nanospheres as an efficient peroxidase mimetic for colorimetric sensing. Colloids Surf. A Physicochem. Eng. Asp. 577, 622–629 (2019).
- 27. Colorimetric determination of ascorbic acid and the activity of alkaline phosphatase based on the inhibition of the peroxidase-like activity of citric acid-capped Prussian Blue nanocubes. Mikrochim. Acta 186(2), 123 (2019).
- 28. Prussian blue modified iron oxide magnetic nanoparticles and their high peroxidase-like activity. J. Mater. Chem. 20(24), 5110 (2010).
- 29. Systematic assessment of the toxicity and potential mechanism of graphene derivatives in vitro and in vivo. Toxicol. Sci. 167(1), 269–281 (2019).
- 30. Nanomaterial cytotoxicity is composition, size and cell type dependent, part. Part. Fibre Toxicol. 7(7), 22 (2010).
- 31. Size effect on the cytotoxicity of layered black phosphorus and underlying mechanisms. Small 13(32), 1701210 (2017).
- 32. Size dependent biodistribution and toxicokinetics of iron oxide magnetic nanoparticles in mice. Nanoscale 7(2), 625–636 (2015).
- 33. . Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat. Biotechnol. 33(9), 941–951 (2015). • Prussian blue-like substance shows size-dependent biodistribution.
- 34. . An assessment of the clinical utility of serum ALT and AST in chronic hepatitis C. Hepatol. Res. 18(1), 63–71 (2000).
- 35. . Overview of optical and electrochemical alkaline phosphatase (ALP) biosensors: recent approaches in cells culture techniques. Biosensors (Basel) 9(3), (2019).
- 36. . Creatinine. Curr. Opin. Crit. Care 16(6), 562–567 (2010).
- 37. An elevation of BUN/creatinine ratio in patients with hyperthyroidism. Horm. Metab. Res. 18(11), 771–774 (1986).